Industry News
Biotechnology Industry News
The Alzheimer’s debate may not seem positive, but AC Immune’s CEO promises it’s been a breakthrough year
The Alzheimer's debate may not seem positive, but AC Immune's CEO promises it's been a breakthrough year aarmstrong Mon, 12/20/2021 - 19:53
2022 forecast: We wish we had better news for biotech dealmaking, but omicron is coming anyway
2022 forecast: We wish we had better news for biotech dealmaking, but omicron is coming anyway aarmstrong Mon, 12/20/2021 - 15:15
No data, no problem. Senti will go public in $296M SPAC deal before hitting the clinic
No data, no problem. Senti will go public in $296M SPAC deal before hitting the clinic aarmstrong Mon, 12/20/2021 - 13:06
Aptose finally ditches APTO-253 after 3-year clinical hold, phase 1 dud
Aptose finally ditches APTO-253 after 3-year clinical hold, phase 1 dud aarmstrong Mon, 12/20/2021 - 11:59
This is just the Spark: Roche’s new gene therapy manufacturing center leaves space for growth
This is just the Spark: Roche's new gene therapy manufacturing center leaves space for growth aarmstrong Mon, 12/20/2021 - 10:50
Roche adds to Genentech’s ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics’ asset
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset aarmstrong Mon, 12/20/2021 - 10:12
Novartis brings on first TIGIT drug in massive billion-dollar biobucks deal with BeiGene
Novartis brings on first TIGIT drug in massive billion-dollar biobucks deal with BeiGene aarmstrong Mon, 12/20/2021 - 09:37
Forbion arms biotech to stop sudden cardiac death, leading $35M round to fund phase 2 trial of Armgo’s pipeline-in-a-product
Forbion arms biotech to stop sudden cardiac death, leading $35M round to fund phase 2 trial of Armgo's pipeline-in-a-product ntaylor Mon, 12/20/2021 - 06:11
Novartis suffers shock setback as Xolair successor fails phase 3
Novartis suffers shock setback as Xolair successor fails phase 3 ntaylor Mon, 12/20/2021 - 03:07
2022 forecast: Pharma has the tools. Will clinical trials be less white in next year?
2022 forecast: Pharma has the tools. Will clinical trials be less white in next year? klahucik Fri, 12/17/2021 - 14:00
Roche’s Spark unit blueprints $575M gene therapy manufacturing center in Philly
Roche's Spark unit blueprints $575M gene therapy manufacturing center in Philly aarmstrong Fri, 12/17/2021 - 10:47
2022 forecast: Talent war in life sciences, salary inflation in C-suite builds to ‘negative feedback loop’
2022 forecast: Talent war in life sciences, salary inflation in C-suite builds to 'negative feedback loop' klahucik Thu, 12/16/2021 - 18:58
Precisely targeting liver cancer with logic-gated gene therapy
Precisely targeting liver cancer with logic-gated gene therapy aliu Thu, 12/16/2021 - 07:03
Abbott gifts $1M to Howard University in effort to diversify clinical trials
Abbott gifts $1M to Howard University in effort to diversify clinical trials jkeenan Wed, 12/15/2021 - 10:58
Abbott gifts $1M to Howard University in effort to diversify clinical trials
Abbott gifts $1M to Howard University in effort to diversify clinical trials jkeenan Wed, 12/15/2021 - 10:58
FHI Clinical acquires South African CRO to expand global footprint
FHI Clinical acquires South African CRO to expand global footprint jkeenan Wed, 12/15/2021 - 10:26
FHI Clinical acquires South African CRO to expand global footprint
FHI Clinical acquires South African CRO to expand global footprint jkeenan Wed, 12/15/2021 - 10:26
Turns out Galera’s radiotherapy complication drug did work after all, and investors are thrilled
Turns out Galera's radiotherapy complication drug did work after all, and investors are thrilled aarmstrong Tue, 12/14/2021 - 14:21
Preventing cancer metastasis by keeping dormant tumor cells asleep with collagen
Preventing cancer metastasis by keeping dormant tumor cells asleep with collagen arlene.weintraub Mon, 12/13/2021 - 09:52
UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal
UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal aarmstrong Mon, 12/13/2021 - 09:12